rs587780519
- chr6-29673737-C-T
- chrNT_113891.3-1160210-C-T
- chrNT_167245.2-939283-C-T
- chrNT_167246.2-938851-C-T
- chrNT_167247.2-939111-C-T
- chrNT_167248.2-939238-C-T
- chrNT_167249.2-982769-C-T
- chr6-29673737-C-G
- chrNT_113891.3-1160210-C-G
- chrNT_167245.2-939283-C-G
- chrNT_167246.2-938851-C-G
- chrNT_167247.2-939111-C-G
- chrNT_167248.2-939238-C-G
- chrNT_167249.2-982769-C-G
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001109809.5(ZFP57):c.374G>A(p.Arg125Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0164 in 1,613,016 control chromosomes in the GnomAD database, including 319 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001109809.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFP57 | NM_001109809.5 | c.374G>A | p.Arg125Gln | missense_variant | 5/5 | ENST00000376883.2 | NP_001103279.2 | |
ZFP57 | NM_001366333.2 | c.158G>A | p.Arg53Gln | missense_variant | 4/4 | NP_001353262.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFP57 | ENST00000376883.2 | c.374G>A | p.Arg125Gln | missense_variant | 5/5 | 5 | NM_001109809.5 | ENSP00000366080 | P1 | |
ZFP57 | ENST00000488757.6 | c.158G>A | p.Arg53Gln | missense_variant | 4/4 | 1 | ENSP00000418259 |
Frequencies
GnomAD3 genomes AF: 0.0137 AC: 2090AN: 152202Hom.: 21 Cov.: 32
GnomAD3 exomes AF: 0.0165 AC: 3988AN: 241450Hom.: 54 AF XY: 0.0177 AC XY: 2342AN XY: 132472
GnomAD4 exome AF: 0.0167 AC: 24376AN: 1460696Hom.: 298 Cov.: 32 AF XY: 0.0173 AC XY: 12567AN XY: 726676
GnomAD4 genome AF: 0.0137 AC: 2091AN: 152320Hom.: 21 Cov.: 32 AF XY: 0.0144 AC XY: 1073AN XY: 74486
ClinVar
Submissions by phenotype
Diabetes mellitus, transient neonatal, 1 Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 24, 2023 | - - |
Transitory neonatal diabetes mellitus Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | ZFP57 gene mutations are associated with neonatal diabetes, however the role of this particular variant (rs114591600) of ZFP57 gene remains uncertain and needs further clinical validation. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 04, 2013 | - - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Dec 21, 2018 | ACMG criteria: BP4 (REVEL 0.004, 10 predictors), BA1 (3.6% gnomAD EF, 3.3% SA, 1.7% ENF), BS2 (216 cases and 229 controls in type2diabetesgenetics.org)= benign - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at